Soleno Therapeutics Inc. buy Wells Fargo & Company
Start price
27.02.26
/
50%
€32.80
Target price
27.02.27
€93.24
Performance (%)
36.07%
Price
17.04.26
€44.20
Summary
This prediction is currently active. The BUY prediction by Wells_Fargo___Compan for Soleno Therapeutics Inc. has seen massive gains of 36.07%. This prediction currently runs until 27.02.27. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Soleno Therapeutics Inc. | -1.207% | -1.207% |
| iShares Core DAX® | 3.593% | 3.931% |
| iShares Nasdaq 100 | 5.810% | 5.518% |
| iShares Nikkei 225® | 4.075% | 8.460% |
| iShares S&P 500 | 4.142% | 4.039% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Soleno Therapeutics Inc. diskutieren
Soleno Therapeutics (SLNO) had its price target lowered by Wells Fargo & Company from $114.00 to $110.00. They now have an "overweight" rating on the stock.
Ratings data for SLNO provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for Soleno Therapeutics Inc.
Soleno Therapeutics Inc.
Start price
Target price
Perf. (%)
€57.65
20.08.25
20.08.25
€105.76
20.08.26
20.08.26
-22.58%
17.04.26
17.04.26
